The new company, a spinoff of Take Solutions' life sciences business, will focus on the life sciences domain to compete with industry leaders
European firm proposes to invest in Dr Datsons' manufacturing facilities and manufacture & co-market 20 nutraceutical products in India
Convergence shareholders will eligible to receive additional payments up to $475 million contingent on future milestones
Trophos will receive an upfront payment of Euro 120 mn, and additional payments of up to Euro 350 mn based on achievement of certain predetermined milestones
Patents, which are valid through 2030, have been granted for the new chemical entity, which can be used for the treatment of disorders associated with neurodegenerative diseases
As per the pact, Strides Arcolab will manufacture and distribute tenofovir alafenamide (TAF) based HIV treatments in 112 developing countries
Acquisition to strengthen Air Liquide's home healthcare offering and enabling the company to consolidate its position in the German infusion therapy market
In this interview, Vikram Prabhu of DuPont Industrial Biosciences, discusses the market potential of bio-based ingredients and role India can play in the global industrial biotechnology arena
Ajay Piramal-promoted healthcare major is holding talks with University of Kentucky to acquire Coldstream, which operates a USFDA-approved facility, for $ 30.65 million (about Rs 188 cr)
Dapsone, also known as diaminodiphenyl sulfone, is an antibiotic commonly used in combination with rifampicin and clofazimine for the treatment of leprosy
Transaction was a result of a deal, signed last year, as per which Novartis and GlaxoSmithKline agreed to merge their global consumer healthcare businesses
The patent dispute, which was settled in IPAB, was over the patent of Hepatitis B drug entecavir, owned by Bristol-Myers Squibb (BMS)
This IT solution will help improve access to health benefits for 24,000 members on its LA Care Covered plan offered through the Covered California health insurance marketplace
Novartis had moved the Delhi High Court in December last year, seeking to restrain Cipla from selling the generic version of Onbrez
The company plans to launch this natural sea based vegetarian product tentatively by April 2015
The company will accelerate the growth of NPS Pharma's innovative portfolio through its market expertise in gastrointestinal disorders, core capabilities in rare disease patient management, etc
Significantly expands AMRI's analytical services capabilities and extends drug development services to include sterile injectable formulation development
Prior to Jubilant, Singh had served as president of Sun Pharmaceuticals, USA
The company's valsartan tablet is the AB rated generic equivalent of Novartis' Diovan tablet, which had annual US sales of $2.08 bn
The company was granted product patents for its new chemical entities, which are used to treat disorders associated with neurodegenerative diseases